The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes,iwas incorrectly told the sp had been 50p. Surely never mind % which i admit was not correct. The fact remains the sp reflects a very poor performance for a company the we are told is providing life changing/improving unique products. One of the worst investments ever recommended by Questor in the DT, his admision and apology has been noted.
5 years ago - Monday 5th December 2016 the SP close was 22.941. Yes it was all over the place and had been higher and lower but I think my point is valid - Your 10% of the SP 4/5 years ago is just plain wrong and the mcap is now substantially higher than 5 years ago - which is a more meaningful number anyway.
sp peaked at 35 p five years ago
Further to the below: there are currently around 430m shares in issue compared to around 150m 5 years ago so even with a lower share price the mcap is significantly higher.
I don’t disagree that the commercial progress is disappointing here, just that your suggestion of the ‘destruction of shareholder value’ is not accurate.
Ironknut: you asked the question: why is KMK worth 10% of its SP 4/5 years ago. The SP was around 25p 5 years ago - so it’s currently around 50% of the SP and given the share issuances in the interim the mcap will be significantly more than 50%.
Its not that they don’t trust KMK, its the boffin sitting in the CEO position that is the problem. In a bull market he’s treated the shareholder trust & investment like a sponsored lab experiment and has no idea how to commercialise
Aqc.
It's great that there are opposing views - especially those like yourself who understand the grey areas and the range of potential outcomes for the company. I do think of all the stocks I own this is the hardest one to judge.
I do think prom did a "piers morgan" sulking off on a couple of facts, I didn't see anything in the prior posts that was inappropriate. If you hold the office and benefit of a CEO, you really do need to be subject to reasonable question and scrutiny on what you have said you will do and then what you have done.
I always find opposing views the most interesting. Would be a pretty useless forum of no value, if it were an echo chamber for pro or anti views. Promethium comments all seemed pretty reasonable, not sure why you’d call him such names just because he has opposing views?
look through Promethium's posts he is clearly a devious ramper of some sort good riddance. Any genuine investor will be be showing frustration as the shareprice sits near all time lows after once more Arnab has promised the world.
Honest opinion seen as rudeness. would have preferred an answer to the question i am not alone in asking.
Well Promethium ,please explain why Kromek is worth less than 10% of its sp of 4/5 years ago,given it is a company that has provided what are described as life improving and life saving unique products. Would have more success making buckets with holes in.Some gardeners would find a use for them,but profit margins would not, i think be high. smoke and Mirrors company,sorry to repeat myself but struggle to think of a better name.
Acq.
Absolutely correct in the 5p to 50p price range, could go either way which in itself isn't a great vote of confidence in the BOD.
Someone can at the same time be an outstanding leading scientist and technician while being an incompetent business person.
Promethium - The only award he deserves is the worst performing CEO award. In 8 years he has delivered a -80% return on investment in a raging bull market.
It’s the best endorsement to date that the biological pathogen detector works -“scientific advances of immeasurable significance, and commitment to the global advancement of security and our health.”
I don’t think the Institute of Physics would make such a comment without knowledge the detector works...
Well done Basu. Wonder what weird world these boffins live in. Which company is producing these wonderful life saving and life changing products. Being selfish i would like to buy shares in that company to make a bit of money enjoying the great benefits Basu has brought to man-kind.
Kromek CEO awarded Honorary Fellowship
30/11/2021
Dr Arnab Basu, the chief executive of Sedgefield-based Kromek Group plc has been honoured with the highest accolade bestowed by the Institute of Physics (IOP), an honorary fellowship.
The IOP is the professional body and learned society for physics in the UK and Ireland. The honorary fellowship is the highest accolade it offers, to reflect an individual’s exceptional services to physics.
Dr Basu has been recognised by the IOP for: ‘outstanding and ongoing contributions to business in the field of physics-based technological innovation, scientific advances of immeasurable significance, and commitment to the global advancement of security and our health.’
As founding chief executive of university spin-out, Kromek, Dr Basu has grown the company into a global market, exporting products to more than 40 countries, and employing in excess of 150 people, including at sites in Pennsylvania and California.
Kromek’s central aim is to deliver detection capabilities which make the world safer and healthier. Its developments cover sectors including radiation and nuclear detection for deployment in civil and defensive environments, and medical imaging for the early diagnosis of life-shortening or limiting conditions such as cancers and osteoporosis. Most recently, Kromek has diversified into biosecurity, developing the world’s first airborne covid-19 detection machine, as well as a broad-spectrum device which could be used to build national or global early warning system for pathogens, emergence and spread.
Dr Arnab Basu MBE DL, said: “It is tremendous honour to receive this prestigious recognition from the Institute of Physics and a testament to the exceptional dedication and ingenuity of my team at Kromek. We are all immensely proud of the work we do and the things we have achieved in delivering innovation to make the world safer and in helping people to live longer, healthier lives.”
Skid, I think the battering is mutual.
People seem to watch the Kromek with a great deal of interest and a greater deal of mistrust.
There is an illogically stampede mentality to the share price going both down and up.
People clearly see the potential by looking at the recent sale of Redlan to Kodak and also by looking at the IP and forthcoming technologies. However they don’t trust Kromek.
I can see further unpredictability here. I wouldn’t be surprised if it ended the year at 5p or 50p. Anything can happen here
Aqc.
You have this the wrong way round. Shareholders have been battered by kmk.
Meanwhile would you be a buyer at 10p ?
I agree with your analysis Guy, Kromek has all the ingredients of a company about to recover and have a turnaround in the sP. Kromek has been so battered by shareholders that even when positive news is announced and they are set to beat this year’s forecasts with exciting new products about to be released, the share price takes a fresh battering. It’s as if some holders think it’s inconceivable that Kromek can pull off any success, the bar is now so low for Kromek that the share price will start reacting drastically when proof of positive progress is announced.
Guy.
Paul Hill is paid to bang the table on kmks behalf, he is really on the lowest rung in terms of the analysts community.
Simon Thompson. He has shown he does not question what the CEO says or provide any further analysis. I remember his arrogant regurgitating the company line that " what you stupid lot don't understand is that aroc will be reversed shortly", that was 2/3 years ago.
We don't really know what their current performance is, the market is assuming they will #### up as they always do but as you say this is built into the share price.
Management have been on the cusp for too long, no doubt about it, but this has created opportunity.
Witness (April 30) 2022 forecast revs (£15m) 75% covered by existing contracts at start of (financial) year. Since then, two contracts announced by RNS for which ~£2.4m could be recognized this year taking announced revs to £13.6m. Additional contracts announced will take the company closer/ to/ past the forecasts for the year and we could expect Paul Hill, Simon Thompson to pound the table at that point.
Again, management performance has been a problem and might remain so but the current performance of the company is not reflected in the price of the stock. (Of course, I've been buying and will continue to do so if the price falls further so do not have a neutral perspective.)